These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22611223)

  • 1. Psychotropic medications and other non-hormonal treatments for premenstrual disorders.
    Pearlstein T
    Menopause Int; 2012 Jun; 18(2):60-4. PubMed ID: 22611223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychiatric and psychological aspects of premenstrual syndrome].
    Limosin F; Ades J
    Encephale; 2001; 27(6):501-8. PubMed ID: 11865558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent selective serotonin reuptake inhibitors for premenstrual syndromes: A systematic review and meta-analysis of randomised trials.
    Reilly TJ; Wallman P; Clark I; Knox CL; Craig MC; Taylor D
    J Psychopharmacol; 2023 Mar; 37(3):261-267. PubMed ID: 35686687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder.
    Pearlstein T; Yonkers KA
    Expert Opin Pharmacother; 2002 Jul; 3(7):979-91. PubMed ID: 12083997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premenstrual syndrome no progesterone; premenstrual dysphoric disorder no serotonin deficiency.
    van Leusden HA
    Lancet; 1995 Dec; 346(8988):1443-4. PubMed ID: 7490987
    [No Abstract]   [Full Text] [Related]  

  • 6. Premenstrual syndrome and premenstrual dysphoric disorder.
    Biggs WS; Demuth RH
    Am Fam Physician; 2011 Oct; 84(8):918-24. PubMed ID: 22010771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management strategies for premenstrual syndrome/premenstrual dysphoric disorder.
    Jarvis CI; Lynch AM; Morin AK
    Ann Pharmacother; 2008 Jul; 42(7):967-78. PubMed ID: 18559957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of premenstrual disorders.
    Kroll R; Rapkin AJ
    J Reprod Med; 2006 Apr; 51(4 Suppl):359-70. PubMed ID: 16734319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacologic management of premenstrual dysphoric disorder.
    Rapkin AJ; Winer SA
    Expert Opin Pharmacother; 2008 Feb; 9(3):429-45. PubMed ID: 18220493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical management of premenstrual dysphoric disorder.
    Yonkers KA
    J Gend Specif Med; 1999; 2(3):55-60. PubMed ID: 11252853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective serotonin reuptake inhibitors for premenstrual syndrome.
    Marjoribanks J; Brown J; O'Brien PM; Wyatt K
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001396. PubMed ID: 23744611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premenstrual Syndrome: Evidence-based Evaluation and Treatment.
    Appleton SM
    Clin Obstet Gynecol; 2018 Mar; 61(1):52-61. PubMed ID: 29298169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premenstrual Syndrome and Premenstrual Dysphoric Disorder.
    Hofmeister S; Bodden S
    Am Fam Physician; 2016 Aug; 94(3):236-40. PubMed ID: 27479626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder.
    Freeman EW
    CNS Drugs; 2004; 18(7):453-68. PubMed ID: 15139800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PMS and PMDD in the domain of mental health nursing.
    Stearns S
    J Psychosoc Nurs Ment Health Serv; 2001 Jan; 39(1):16-27. PubMed ID: 11197992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premenstrual syndrome: A mini review.
    Ryu A; Kim TH
    Maturitas; 2015 Dec; 82(4):436-40. PubMed ID: 26351143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sertraline in the treatment of premenstrual dysphoric disorder].
    Culav-Sumić J; Skocilić Z; Jukić V
    Lijec Vjesn; 1999; 121(7-8):234-8. PubMed ID: 10573958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study.
    Jermain DM; Preece CK; Sykes RL; Kuehl TJ; Sulak PJ
    Arch Fam Med; 1999; 8(4):328-32. PubMed ID: 10418540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of premenstrual dysphoric disorder.
    Brechin S; Owen P
    Hosp Med; 2003 Jun; 64(6):348-51. PubMed ID: 12833829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder.
    Freeman EW; Rickels K; Sondheimer SJ; Polansky M; Xiao S
    Am J Psychiatry; 2004 Feb; 161(2):343-51. PubMed ID: 14754784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.